Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

SL Kulasingam, JP Hughes, NB Kiviat, C Mao… - Jama, 2002 - jamanetwork.com
ContextHuman papillomavirus (HPV) DNA testing of women having Papanicolaou (Pap)
smears showing atypical squamous cells of undetermined significance (ASCUS) has clinical …

Comparison of human papilloma virus testing and spectroscopy combined with cervical cytology for the detection of high-grade cervical neoplasia

CL Werner, WF Griffith III, R Ashfaq… - Journal of Lower …, 2007 - journals.lww.com
Objective. This study compared the performance of cervical cytology plus human papilloma
virus testing (Pap+ HPV) or cervical spectroscopy (Pap+ CS) for identifying high-grade …

Combining human papillomavirus testing or cervicography with cytology to detect cervical neoplasia

M Howard, JW Sellors, A Lytwyn… - … of pathology & …, 2004 - meridian.allenpress.com
Context.—Cervicography and oncogenic human papillomavirus (HPV) testing have been
proposed for improving the accuracy of cervical cancer screening. Objective.—To examine …

Cervical cancer screening in the 21st century: is it time to retire the PAP smear?

JR THOMAS C WRIGHT - Clinical obstetrics and gynecology, 2007 - journals.lww.com
Although cytology-based cervical cancer prevention programs have reduced the incidence
of cervical cancer in many industrialized countries, the limited sensitivity of cervical cytology …

Human papillomavirus testing in cervical cancer screening

PE Castle, M Cremer - Obstetrics and Gynecology Clinics, 2013 - obgyn.theclinics.com
Human Papillomavirus Testing in Cervical Cancer Screening - Obstetrics and Gynecology
Clinics Skip to Main Content Advertisement Obstetrics & Gynecology Clinics Log in Register Log …

Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice

W Kinney, B Fetterman, JT Cox, T Lorey… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: To characterize the cervical cancers diagnosed following a Pap-negative, high
risk human papillomavirus (HPV)-positive (Pap−/HPV+) screen in routine clinical practice …

[HTML][HTML] The value of adding a single co-test in HPV primary screening

L Jans, K Zetterström, L Bergengren, G Helenius - Preventive Medicine, 2021 - Elsevier
The screening program for cervical cancer in Sweden, recommends screening with HPV test
primarily for women over 30 years, but at the first screening test that is performed after the …

Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: a retrospective study in 314 cases

C Infantolino, P Fabris, D Infantolino, MR Biasin… - European Journal of …, 2000 - Elsevier
Objective: To assess the usefulness of human papilloma virus (HPV) typing for predicting
pre-malignant and malignant cervical lesions. Study design: 314 women, who underwent …

Chapter 13: Primary screening of cervical cancer with human papillomavirus tests

EL Franco - JNCI Monographs, 2003 - academic.oup.com
Despite its history of success in cancer screening, Pap cytology has important limitations,
particularly its high false-negative rate, which carries important public health implications …

Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity …

RH Kaufman, E Adam, J Icenogle… - American journal of …, 1997 - Elsevier
OBJECTIVE: Our purpose was to evaluate the cost-effectiveness of the use of a Food and
Drug Administration–approved human papillomavirus test in triaging patients with …